Invention Grant
- Patent Title: Compounds as tyrosine kinase modulators
-
Application No.: US15269612Application Date: 2016-09-19
-
Publication No.: US09725433B2Publication Date: 2017-08-08
- Inventor: Xialing Guo , Zhen Zhu
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K31/4427 ; C07D401/14 ; C07D405/14 ; C07D409/04 ; C07D409/14 ; C07D413/14 ; C07D405/00
Abstract:
The present invention is directed to novel compounds of Formula I. The compounds of the present invention are potent tyrosine kinase modulators, and are suitable for the treatment and prevention of diseases and conditions related to abnormal activities of tyrosine kinase receptors.
Public/Granted literature
- US20170066738A1 COMPOUNDS AS TYROSINE KINASE MODULATORS Public/Granted day:2017-03-09
Information query
